Literature DB >> 10194525

The influence of the colon on postprandial glucagon-like peptide 1 (7-36) amide concentration in man.

M D Robertson1, G Livesey, L M Morgan, S M Hampton, J C Mathers.   

Abstract

Glucagon-like peptide (7-36) amide (GLP-1) is an incretin hormone of the enteroinsular axis released rapidly after meals despite the fact that GLP-1 secreting cells (L-cells) occur predominantly in the distal gut. The importance of these colonic L-cells for postprandial GLP-1 was determined in healthy control subjects and in ileostomy patients with minimal small bowel resection (<5 cm). Subjects were fed a high complex carbohydrate test meal (15.3 g starch) followed by two carbohydrate-free, high fat test meals (25 g and 48.7 g fat respectively). Circulating levels of glucose, insulin, glucagon, glucose insulinotrophic peptide (GIP) and GLP-1 were measured over a 9-h postprandial period. For both subject groups the complex carbohydrate test meal failed to elicit a rise in either GIP or GLP-1. However, both hormones were elevated after the fat load although the GLP-1 concentration was significantly reduced in the ileostomist group when compared with controls (P=0.02). Associated with this reduction in circulating GLP-1 was an elevation in glucagon concentration (P=0.012) and a secondary rise in the plasma glucose concentration (P=0.006). These results suggest that the loss of colonic endocrine tissue is an important determinant in the postprandial GLP-1 concentration. Ileostomists should not be assumed to have normal enteroinsular function as the colon appears to have an important role in postprandial metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194525     DOI: 10.1677/joe.0.1610025

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

1.  Gastric emptying rate of solids is reduced in a group of ileostomy patients.

Authors:  M D Robertson; J C Mathers
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 2.  Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives.

Authors:  Hubert Zatorski; Maciej Sałaga; Jakub Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-29       Impact factor: 3.000

3.  Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects.

Authors:  M D Robertson; J M Currie; L M Morgan; D P Jewell; K N Frayn
Journal:  Diabetologia       Date:  2003-04-24       Impact factor: 10.122

4.  Fluctuation of blood glucose levels in an infant with an ileostomy on continuous glucose monitoring: A case report.

Authors:  Seiichi Tomotaki; Tetsuo Naramura; Junko Hanakawa; Katsuaki Toyoshima; Koji Muroya; Masanori Adachi
Journal:  Clin Pediatr Endocrinol       Date:  2018-01-30

Review 5.  Role of Incretin Axis in Inflammatory Bowel Disease.

Authors:  Lihua Duan; Xiaoquan Rao; Zachary Braunstein; Amelia C Toomey; Jixin Zhong
Journal:  Front Immunol       Date:  2017-12-06       Impact factor: 7.561

6.  Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme-linked immunosorbent assay.

Authors:  Toshihiro Matsuo; Jun-Ichiro Miyagawa; Yoshiki Kusunoki; Masayuki Miuchi; Takashi Ikawa; Takafumi Akagami; Masaru Tokuda; Tomoyuki Katsuno; Akira Kushida; Takashi Inagaki; Mitsuyoshi Namba
Journal:  J Diabetes Investig       Date:  2015-08-24       Impact factor: 4.232

Review 7.  Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1.

Authors:  Tamara Zietek; Eva Rath
Journal:  Front Immunol       Date:  2016-04-22       Impact factor: 7.561

8.  Gustducin couples fatty acid receptors to GLP-1 release in colon.

Authors:  Yan Li; Zaza Kokrashvili; Bedrich Mosinger; Robert F Margolskee
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-22       Impact factor: 4.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.